Improving STI Screening Access Across Gender Identities and Sexual Behaviors

Dina Greene, PhD, DABCC, will identify gaps between STI screening guidelines and current testing availability and underscore the value of self-collected specimens in improving access. Dr. Greene will outline method validation experiments that can expand and strengthen STI screening opportunities.

Objectives:

·      List the sites of infection for Chlamydia and Gonorrhea. 

·      Identify gaps between guideline recommendations and testing availability for STI screening. 

·      Illustrate the value of self-collected specimens for STI screening.

·      Define method validation experiments that can increase access to STI screening.

‍

Dina Greene, PhD, DABCC, is a Clinical Professor in the Department of Laboratory Medicine and Pathology at the University of Washington and the founder of Evergreene Labs, a consulting company focused on innovative solutions for common problems in the clinical laboratory. She serves on several committees and working groups for organizations, including the Association for Diagnostic Laboratory Medicine (ADLM) and the College of American Pathologists (CAP). Dr. Greene serves as an Associate Editor for the Clinical Research section of Heliyon (Cell Press), and additionally serves on the Editorial Boards for the Canadian Journal of Cardiology (Elsevier) and Clinical Chemistry and Laboratory Medicine (DeGruyter). Dr. Greene has published over 140 scientific papers and is internationally recognized for her work on gender inclusive laboratory medicine. Her clinical research studies explore the application and effects of laboratory diagnostics, with an emphasis on how social demographics impact clinical outcomes. In line with her clinical focus, Dr. Greene is passionate about designing operational strategies for more inclusive laboratory medicine.

‍

‍